Renal Insufficiency, Chronic Clinical Trial
Official title:
Effects by Omission of Bandage Over Exit Site at Patients in Peritoneal Dialysis (PD).Randomized Controlled Cross-over Study
Peritoneal dialysis, known as p- dialysis (PD), is a dialysis form in which the blood is
purified by using the body's peritoneum. PD dependents on good access to peritoneum. For
this, a catheter is implanted in the peritoneum and tunneled 2-3 cm below the skin. The way
out is called exit site and is close to the navel.
Patients are selected at random to use bandage or not use bandage for three months, then
cross-over. The overall objective of the research is that the patient in PD maintains a
complete and healthy skin without signs of infection around the exit site. In the study
effects by omission of bandage over exit site at patients in PD are examined when the
patients are in a stable process with PD. The patient's exit site is assessed according to
skin character and examined for infection.
The hypothesis is that there is no greater rate of infection in patients without bandage
than in patients with bandage over the exit site, and that patients without bandage will
have stronger skin around exit site.
Background: For a patient in a stable (PD) there is no evidence for using bandage over exit
site. Guidelines refer to this as an unsolved question.
An exit site infection can lead to tunnel infection and to peritonitis, which can be fatal.
For this reason it is very important to prevent exit site infections and at the same time it
is very important to reduce antibiotic which is a general problem in health care. (In
Denmark, the patient does not use antibiotic cream around exit site, preventive.) Few years
back, the care of the exit site was associated with sterile techniques, and the use of
bandage was an obligatory procedure. The risk of infection appears now to be much less than
first thought, but it is unclear what procedures are best: bandage or no bandage.
At present, most patients use bandage, but some patients drop it when bandage leads to
maceration of the skin, allergy or wetness around the exit site. Other patients simply do
not want to use bandage with subjective reasons. A dialysis catheter interferes with the
patient's bodily life, integrity, autonomy and with the social sphere.
The nurses in the PD clinic at Aalborg University Hospital might have observed that patients
without bandage do not get more infections around the exit site in relation to the patients
using bandage. However, the study should develop evidence guidelines.
Objective: The aim of the study is to study the effects by omission of bandage over exit
site at patient in PD when the patient is in a stable course. The purpose is that the
patient maintains an unbroken skin without signs of infection around the exit site.
Design: Randomized controlled cross-over study. Setting: Department of outpatient clinic for
peritoneal dialysis, Departments of Nephrology, Aalborg University Hospital in Region
Northern Denmark.
Participants: The estimated numbers of participants are 35 men and women aged > 18 years.
The patients are in stable PD with uraemia chronic classified by International Statistical
Classification of Diseases and Related Health Problems, Tenth Revision (ICD10) - kode DN189
- and will be enrolling and included by invitations in the outpatient clinic. Exclusion
criteria: special reasons for protection of the exit site - eg. critical illness, stay in
areas with high risk of infection or body movements that require special fixation of the
exit site, do not understand or speak Danish, mental impairment or symptoms of eczema around
the exit site.
Inclusion time: March 2014 to september 2015. Method: By inclusion patients are randomized
to either use or not use bandage. After 3 months the patient will cross over and do the
opposite.
By inclusion investigators collect data to baseline characteristics (age, sex, marital
status, other diseases, smoking, height and weight, medication use, self-reliance, time of
construction of p-catheter, type of catheter, who is caring for the exit site at home and
how often is changing of bandage per. week, previous infections, skin itching). The nurse in
the outpatient clinic also examines a bath instruction with the patient.
The primary endpoint is the condition of the skin around the exit site as measured by
Sunnybrook PD Catheter Exit Site Assessment Tool prepared by Patsy Cho and colleagues.
Following parameters are recorded: Redness, crust, swelling, pain, secretion. The patient is
assessed a total of five times with this skin assessment: at inclusion, after 6 weeks, 3
months (cross-over), 4.5 months and 6 months.
At these four controls investigators also collect data on: Infection, self-reliance, who is
caring for the exit site and how often is changing of bandage per. week, skin itching.
Moreover, the patient must answer a questionnaire on compliance and experiences of wearing
bandage or not wearing bandage.
All data entered in a database. Main outcome measures: The primary endpoint is the condition
of the skin around the exit site. The secondary endpoints will partly be the number of exit
site infections, tunnel infections and peritonitis and the third point is a record of
patient compliance and experiences in relation to participation in the project.
The trial is approved by the local Ethics Committee, registration number: N-20130076
;
Observational Model: Case-Crossover, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05056727 -
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
|
Phase 3 | |
Withdrawn |
NCT01655186 -
A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
|
Phase 2 | |
Completed |
NCT03481686 -
Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections
|
N/A | |
Active, not recruiting |
NCT03672110 -
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
|
Phase 3 | |
Enrolling by invitation |
NCT02237534 -
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
|
Phase 4 | |
Completed |
NCT02126293 -
Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
|
Phase 3 | |
Terminated |
NCT01533545 -
Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients
|
N/A | |
Completed |
NCT03280615 -
Omega 3 Fatty Acids in Patients With Chronic Renal Disease
|
Phase 3 | |
Completed |
NCT04498156 -
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
|
||
Recruiting |
NCT04020328 -
Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
|
Phase 4 | |
Recruiting |
NCT06366529 -
Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction
|
||
Active, not recruiting |
NCT04876963 -
HOLT-ED: Holter-monitoring in End-stage Renal Disease
|
||
Completed |
NCT03836508 -
Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis
|
N/A | |
Completed |
NCT03250715 -
Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure
|
N/A | |
Completed |
NCT03577249 -
Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation
|
Phase 2/Phase 3 | |
Completed |
NCT01975818 -
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
|
Phase 2 | |
Active, not recruiting |
NCT05766644 -
App-based Education Program for CKD
|
N/A | |
Active, not recruiting |
NCT02791880 -
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
|
||
Recruiting |
NCT02947750 -
Neurovascular Transduction During Exercise in Chronic Kidney Disease
|
Phase 2 | |
Terminated |
NCT02286258 -
Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
|
Phase 1/Phase 2 |